Fundz

AVEO Oncology Appoints Edgar E. Braendle as Chief Medical Officer

PRIVATEMar 25, 2024

Position

Chief Medical Officer

Company

AVEO Pharmaceuticals

Edgar E. Braendle
BiotechnologyHealth CareTherapeuticsBiopharma

Description

AVEO Oncology appoints Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer. Dr

Quick answer

AVEO Oncology Appoints Edgar E. Braendle as Chief Medical Officer (March 25, 2024).

Who is the new Chief Medical Officer at AVEO Pharmaceuticals?
AVEO Pharmaceuticals named Edgar E. Braendle Chief Medical Officer, announced March 25, 2024.
What did AVEO Pharmaceuticals announce on March 25, 2024?
AVEO Oncology appoints Edgar E. Braendle, MD, PhD as AVEO Oncology’s new Chief Medical Officer.
What does AVEO Pharmaceuticals do?
AVEO is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer.
Which similar companies made leadership changes around the same time?
Nuvation Bio (March 28, 2024), BioNTech (March 20, 2024), Intra-Cellular Therapies (March 19, 2024) and Aculys Pharma (April 1, 2024) also announced leadership changes within 45 days of AVEO Pharmaceuticals.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at AVEO Pharmaceuticals, and when

A new leader at AVEO Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day AVEO Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AVEO Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AVEO Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AVEO Pharmaceuticals

About

AVEO is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology and other novel targeted combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the company.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AVEO Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Edgar
Senior decision-maker at this company
••••••••@••••••••

See Edgar's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for AVEO Pharmaceuticals's next move

Learn about Strategic plan

AVEO Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.